What Researchers Did
Researchers conducted a prospective observational study to evaluate suPAR as a prognostic marker for necrotising soft tissue infections (NSTI) and to assess if hyperbaric oxygen therapy (HBOT) modulates endothelial damage markers in 150 NSTI patients.
What They Found
This abstract describes the protocol for a prospective observational study involving 150 patients diagnosed with necrotising soft tissue infections (NSTI). The study aims to measure various endothelial and prognostic biomarkers, including suPAR, in blood samples taken on admission and daily after surgery and hyperbaric oxygen therapy (HBOT) over 7 days. No results are available yet as this publication details the study design and methodology.
What This Means for Canadian Patients
If successful, this research could lead to improved risk assessment for Canadian patients with necrotising soft tissue infections, potentially guiding more timely and effective treatment strategies. Understanding the role of biomarkers and hyperbaric oxygen therapy might help reduce mortality and long-term complications like amputations for these critically ill individuals.
Canadian Relevance
This study has no direct Canadian connection as it is being conducted at a tertiary hospital in Copenhagen, Denmark.
Study Limitations
As this is a study protocol, actual findings are not yet available, and the observational design inherently limits causal inferences.